Hutchmed (china) Share Discussion Threads

[steeplejack] 10/3/2016 15:37

3/8/2016 9:30:18 AM

Hutchison China MediTech (Chi-Med), a company developing novel drugs for oncology and autoimmune diseases, is scheduled to raise $100 million by listing ADS shares on the NASDAQ exchange. The offering values Chi-Med at almost $1 billion. Each ADS will be equal to one-half of each London-traded Chi-Med share. Chi-Med will issue 6.1 million ADSs at a price to be determined by demand, though it will probably be close to one-half the present London ADS value, or $16.33 each. The underwriters have the option of placing another $15 million of stock to cover overallotments. The transaction is scheduled to take place the week of March 14th.

Yes,it looks like it's been oversubscribed.Hopefully ,by substantially more than the $15m greenshoe.

[nhb001] 10/3/2016 12:17

I guess it's all about the price. Any sign what the IPO shares will be priced at. Do they have to proceed at the same as the AIM converted or can they be priced less to lure people in?

[nerdofsteel] 10/3/2016 11:51

Looks as if the IPO is over-subscribed

hxxp://www.globalcorporateventuring.com/article.php/13424/chi-med-aims-for-115m-in-us-ipo

[nerdofsteel] 08/3/2016 13:51

The NASDAQ IPO website has been updated in the last few minutes with an expected IPO date of the 17th March

[nerdofsteel] 08/3/2016 13:48

Looking at the Beigene timetable, looks very much like we are in the final stages now, and for the first time, we now appear on the NASDAQ Upcoming IPO page

Now the ADR's are priced it is a matter of a few days

[miti 1000] 08/3/2016 12:45

It's from this site , presumably , although a few other US ipo sites have the same data. I doubt very much it will be next week , but I'll be happy to be proved wrong.

hxxp://www.renaissancecapital.com/health-care/hutchison-china-meditech/ipo-hcm.html

[jatin724] 08/3/2016 08:14

Hi Nerdofsteel - I wasn't aware that the IPO was scheduled for next week - can I ask where you have seen this info

[nerdofsteel] 08/3/2016 06:10

IPO scheduled for next week - looks like it will raise a lot more than $100m

[nerdofsteel] 06/3/2016 16:50

User of commercial platform profits to part fund drug development thus avoiding the usual AIM dilution - brilliant strategy, this Company continues to over deliver.

[steeplejack] 01/3/2016 16:25

Yes,looks good.Roll on a NASDAQ listing so we can lessen dependence on AIM

[nerdofsteel] 01/3/2016 16:06

Yet again we have revenue up in excess of 100% Y-on-Y, more cash generation, and most critically the Company continues to deliver against its strategy and vision.

[steeplejack] 01/3/2016 07:14

Group Results-- Revenue up 104% to $178.2 million (2014: $87.3m).-- Net profit from operations attributable to Chi-Med of $8.0 million (2014: net loss -$7.3m), including our booking of $3.1 million in one-time preparation costs for our proposed Nasdaq listing.-- Stable cash position: Available cash of over $90 million as of today, at the Chi-Med Group level, including cash and cash equivalents and unutilized banking facilities.1. $31.9 million in cash and cash equivalents at Chi-Med Group level as at 31 December 2015;2. $6.9 million in unutilized bank facilities at Chi-Med Group level as at 31 December 2015;3. $60.0 million additional unsecured bank facilities established in February 2016;4. $76.9 million in further cash and cash equivalents held at 50/50 Joint Venture ("JV") level and not consolidated at Chi-Med Group level. Shanghai property compensation of approximately $73.9 million expected at JV level in 2016, which is in addition to the $31.1 million that we already received in late 2015.-- Continued focus on proposed Nasdaq dual listing - fourth public filing of registration statement on Form F-1 expected to be made today.

[essential] 29/2/2016 16:19

Results tomorrow?

[reptile3] 24/2/2016 10:19

Maybe it's because the nyse arca pharmaceutical index has fallen steeply from 604 in July 2015 to 477 this February. After all it took six years for the index to rise steadily from 220 in March 2009 to the peak last July. I seem to recall the company said they would have regard to market conditions.

[nerdofsteel] 18/2/2016 15:21

Why is the IPO taking so long

We originally filed at the same time as Beigene

[d40eq6] 11/2/2016 18:13

Nice encouraging update on the NASDAQ listing post close.

[steeplejack] 11/2/2016 11:50

Yes,free float of only 29.6%.Even a small Nasdaq listing will help liquidity.

[nerdofsteel] 07/2/2016 09:20

Closely held, lightly traded, I think that could change once the NASDAQ IPO is done

[nhb001] 05/2/2016 13:39

HCM is a £1.3+ billion company but it's price can be moved 3% by 5K of sales.

[nerdofsteel] 04/2/2016 10:19

Beigene IPO oversubscribed and healthy rise in share price yesterday

Our IPO is on track - news coming very shortly. I wouldn't be surprised if we are also oversubscribed as there is still a very big appetite for Biotechs with a broad and deep pipeline/.

[jprouten] 02/2/2016 17:18

Nice steady recovery. Bring on results next month

[cisk] 26/1/2016 23:46

$100m IPO in the context of the market cap is fairly small.

Suspect, as others have eluded to, the fall is due to a few larger sells and worries about China.

I don't for one minute think the bottom is about to fall out of the market for their products in China.

Maybe there's some bad news coming for one of the drugs in late stage trials. I'm not expecting every drug to become a blockbuster - it will probably only take one from the 6 or 7 in the pipeline to do revenue more than the current market cap.

[steeplejack] 26/1/2016 16:40

Understandably the prospect of being listed solely on the scrubby AIM market doesn't really appeal but the company has a good portfolio of drugs.I'd settle for the company simply stepping up to a full UK listing.

[nerdofsteel] 26/1/2016 16:35

It will be interesting to see what happens to Beigene's $100m IPO that's scheduled for the 4th Feb. They have a tiny pipeline and if they can get it away there's nothing at the moment to suggest our IPO will not be successful